The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Stream Link:

8 PM ET: https://globalmeet.webcasts.co...

Program Description

IgA nephropathy (IgAN) can result in progressive kidney damage that can significantly impact patients’ quality of life. Additionally, as the progression of IgAN varies significantly among individuals, it can be challenging to predict patient outcomes. This webinar will focus on the practical application of the latest IgAN research and guidelines through a comprehensive case-based analysis of real-world patient scenarios. Each case will emphasize distinct clinical presentations of IgAN and review treatment challenges. Throughout the case discussions, expert faculty will emphasize treatment interventions and evidence-based management of IgAN. Participants will be challenged to apply the updated 2025 KDIGO guidelines to treatment approaches, review appropriate use of disease-modifying agents, and discuss the role of recently approved and emerging therapies. Managed care and operational strategies to optimize access to novel therapies will also be covered.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: June 19, 2025
Expiration date: August 19, 2025

Time to complete activity: 1.0 hour

Learner level: Foundational

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Apply recommendations from the KDIGO guidelines for the screening and treatment of patients with IgA nephropathy (IgAN).
• Explore the use of disease management protocols and care pathways in treatment selection for patients with IgAN through case discussions.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number N/A. The activity is available for CE credit through August 19, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Darren W. Grabe, BS, PharmD

Joanna A. Hudson, PharmD, BCPS, FASN, FCCP, FNKF

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms